Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii. A multi-centre clinical experience INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2024
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 2024
Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis CLINICAL AND EXPERIMENTAL MEDICINE 2024
Insights into Long COVID: Unraveling Risk Factors, Clinical Features, Radiological Findings, Functional Sequelae and Correlations: A Retrospective Cohort Study THE AMERICAN JOURNAL OF MEDICINE 2024
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19 ANTIOXIDANTS 2024
Astronomy potential of KM3NeT/ARCA EUROPEAN PHYSICAL JOURNAL. C, PARTICLES AND FIELDS 2024
Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2024
Epicardial fat and liver stiffness by ARFI elastography in people living with Human Immunodeficiency Virus type 1 (HIV-1) infection without liver disease AIDS 2024
Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing K. pneumoniae bloodstream infection: a retrospective cohort study JAC-ANTIMICROBIAL RESISTANCE 2024
Efficacy of Fosfomycin-Containing Regimens in Treating Severe Infections Caused by KPC-Producing Klebsiella pneumoniae and Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2024
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route VACCINES 2024
The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study HELIYON 2024
High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study JOURNAL OF FUNGI 2023
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection CIRCULATION RESEARCH 2023
Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University hospital in Rome BMC PULMONARY MEDICINE 2023
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients INTERNAL AND EMERGENCY MEDICINE 2023
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2023
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with hiv JOURNAL OF MEDICAL VIROLOGY 2023
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients MICROORGANISMS 2023
Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection PATHOGENS 2023

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma